Trials / Sponsors / Mersana Therapeutics
Mersana Therapeutics
Industry · 11 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Non-Small Cell Lung Cancer | Phase 1 | 2023-01-24 |
| Recruiting | A Study of XMT-1660 in Participants With Solid Tumors Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer | Phase 1 | 2022-08-15 |
| Terminated | Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 3 | 2022-06-23 |
| Terminated | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Platinum-sensitive Ovarian Cancer (UPGRADE-A) | Phase 1 | 2021-06-11 |
| Terminated | First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b Ovarian Cancer, Nonsmall Cell Lung Cancer | Phase 1 | 2020-05-11 |
| Completed | First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b Platinum Resistant Ovarian Cancer, Non-Small Cell Adenocarcinoma | Phase 1 | 2019-07-30 |
| Active Not Recruiting | First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b Platinum Resistant Ovarian Cancer, Non Small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | 2017-12-12 |
| Completed | First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b Platinum Resistant Ovarian Cancer, Non Small Cell Lung Cancer Metastatic | Phase 1 | 2017-12-12 |
| Completed | Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2 Advanced Breast Cancer, Advanced Nonsmall Cell Lung Cancer, Advanced Gastric Cancer | Phase 1 | 2016-11-21 |
| Completed | A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors Small Cell Lung Cancer, Non-small Cell Lung Cancer | Phase 1 | 2011-03-01 |
| Completed | A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors Neoplasm Metastasis | Phase 1 | 2010-03-01 |